To cite this paper use one of the standards below:
Studies with organisms from marine habitat have provided to be a rich source of secondary metabolites with therapeutic potential. Among marine organisms, invertebrates have been the mainstream source in marine‐derived drug discovery, contributing approximately to 65% of the marine natural products reported to date. Cytotoxic potential for tumor cell lines has been the most biological activity explored, contributing to the emergence of compounds as models for the development of new anticancer drugs such as didemnin B, frondoside A, eribulin, among others. Previous chemical investigations of the sea hare Aplysia dactylomela found worldwide in tropical to warm temperate waters reported the isolation of two principal groups of compounds, terpenes and nonterpenoid C-15 acetogenins exhibiting potential anticancer. Thus, the objective of the present study was to evaluate the antitumor property of extract and fractions of sea hare A. dactylomela collected on the coast of Espirito Santo State, Brazil, through a biomonitoring study in the search for active compounds. For the study, after the collection the sample was freeze-dried and the extract was prepared in non-polar solvents. Fractions were obtained through partition and chromatography and subjected to bioassay-guided isolation. One compound isolated by HPLC showed efficacy in human HCT116 cancer cells. Structure elucidation using NMR and MS is in process.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper